ABVC BioPharma, Inc. Increase (Decrease) in Notes Payable, Current
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Notes Payable, Current of -$23.04 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableCurrent · last filed 2022-03-31
- ABVC BioPharma, Inc. increase (decrease) in notes payable, current for the quarter ending 2020-12-31 was -$23.76K, a 346.72% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in notes payable, current for the quarter ending 2020-09-30 was -$28.43K, a 63286.67% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in notes payable, current for the quarter ending 2019-12-31 was $9.63K.
- ABVC BioPharma, Inc. increase (decrease) in notes payable, current for the quarter ending 2019-09-30 was $45.00.
- ABVC BioPharma, Inc. increase (decrease) in notes payable, current for fiscal 2021 was -$23.04K.
- ABVC BioPharma, Inc. increase (decrease) in notes payable, current for fiscal 2020 was -$951.00.
- ABVC BioPharma, Inc. increase (decrease) in notes payable, current for fiscal 2019 was -$4.86K.
| Period end | Increase (Decrease) in Notes Payable, Current 3 month | Increase (Decrease) in Notes Payable, Current 6 month | Increase (Decrease) in Notes Payable, Current 9 month | Increase (Decrease) in Notes Payable, Current 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$23.04K 10-K · filed 2022-03-31 | |||
| 2020-12-31 | -$23.76K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$52.19K derived: sum of 2 quarters · filed 2022-03-31 | -$951.00 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$28.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $22.81K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $51.24K 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $9.63K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $9.67K derived: sum of 2 quarters · filed 2021-03-16 | -$4.86K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $45.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | -$14.49K 10-Q · filed 2020-11-17 | ||
| 2019-06-30 | -$14.54K 10-Q · filed 2020-08-14 | |||
| 2015-12-31 | -$7.00K 10-Q · filed 2016-02-23 |